Glioblastoma Awareness: Team-Based Approach Helps Those With This Deadly Brain Tumor

Despite advances in understanding the molecular causes and effects of glioblastomas, or GBM, it remains the most common, treatment-resistant, and deadliest type of brain cancer. GBM Awareness Day falls on July 21 — a day when researchers, patients and caregivers put a spotlight on this devastating condition to help improve education and remember those who were stricken. “Despite all the advancements in surgery, radiation and chemotherapy, the outcomes for patients with glioblastoma still remain dismal,” said medical oncologist Manmeet Ahluwalia, M.D., M.B.A, an internationally recognized clinical investigator with Miami Cancer Institute, who specializes in the treatment of brain tumors and brain metastases. “What it means is that we have a lot of work to be done to help our patients live longer — and with a better quality of life.” Want to see more? Baptist Health South Florida’s Resource Blog https://baptisthealth.net/news Like us on Facebook   / baptisthealthsf   Follow Baptist Health on Twitter   / baptisthealthsf   Follow Baptist Health on Instagram   / baptisthealthsf   [Transcript] Manmeet Ahluwalia: Glioblastoma or GBM as it is sometimes referred to, is the most common tumor of the brain. Every year 13,000 or so patients will be diagnosed with glioblastoma in United States. When someone is diagnosed with glioblastoma, we always recommend that patients seek treatment at a center of excellence, like one we have at Miami Cancer Institute. We work in a team based approach, consisting of neurosurgeons, radiation oncologists, medical and neuro-oncologists who have had special training and expertise in treatments of patients with brain tumors. We like to utilize clinical trials as a way of providing best care to our patients at Miami Cancer Institute for glioblastoma and other brain tumors.